Sutter, Boehringer Ingelheim Partner on Drug Research
Sutter Health has announced a new five-year research partnership with drug company Boehringer Ingelheim Pharmaceuticals to test digital health programs and mobile technology for patients with chronic lung disease. The partnership aims to collect patient data, identify gaps in care and improve provider communication about treatment options.
- "Sutter Health Nabs Another Drug Company Research Deal" (Robertson, Sacramento Business Journal, 5/26).